Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC-Reference-Cited by-同舟云学术

Allogeneic hematopoietic stem cell transplantation for adults with therapy-related acute myeloid leukaemia: a retrospective multicentre study on behalf of the SFGM-TC

Published:2023-08-31 Issue:12 Volume:58 Page:1331-1338
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Rey Gaëlle,Daguenet Elisabeth,Bonjean Paul,Devillier Raynier^ORCID,Fegueux Nathalie,Forcade Edouard^ORCID,Srour Micha^ORCID,Chevallier Patrice,Robin Marie,Suarez Felipe,Micol Jean-Baptiste^ORCID,Labussière-Wallet Hélène,Bilger Karin,Daguindau Etienne,Bay Jacques-Olivier,Fayard Amandine,Bulabois Claude-Eric,Nguyen-Quoc Stéphanie,Genthon Alexis,Orvain Corentin^ORCID,Turlure Pascal,Loschi Michael^ORCID,Poiré Xavier,Guillerm Gaëlle,Beguin Yves,Maillard Natacha,Mear Jean-Baptiste,Chalayer Emilie,Cornillon Jérôme,Tavernier Emmanuelle^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

https://www.nature.com/articles/s41409-023-02082-5.pdf

Reference38 articles.

1. McNerney ME, Godley LA, Le Beau MM. Therapy-related myeloid neoplasms: when genetics and environment collide. Nat Rev Cancer. 2017;17:513–27.

2. Wong TN, Ramsingh G, Young AL, Miller CA, Touma W, Welch JS, et al. The role of TP53 mutations in the origin and evolution of therapy-related AML. Nature. 2015;518:552–5.

3. Allan JM, Travis LB. Mechanisms of therapy-related carcinogenesis. Nat Rev Cancer. 2005;5:943–55.

4. Larson RA. Etiology and management of therapy-related myeloid leukemia. Hematology. 2007;2007:453–9.

5. Nenova I, Grudeva-Popova J. Carcinogenic potential of antitumor therapies - is the risk predictable? J BUON. 2017;22:1378–84.